Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Sareum and Structure: An Interview with Tim Mitchell, CEO




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Sareum and Structure: An Interview with Tim Mitchell, CEO
Released on: March 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks to Tim Mitchell, CEO, Sareum, about founding the company with David Williams and John Reader, as a spin-out from Millennium Pharmaceuticals' Structure-based Discovery Department.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton talks to Tim Mitchell, CEO, Sareum, about founding the company with David Williams and John Reader, as a spin-out from Millennium Pharmaceuticals' Structure-based Discovery Department. Tim explains how the company's success is based on the excellent track record and relationships the management established at Millennium Pharmaceuticals and at Cambridge Discovery Chemistry and the efficient structure-based drug discovery services they have refined over the years.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Tim Mitchell has 18 years’ experience in the industry, with key management and business expertise gained from his positions at Cambridge Discovery Chemistry and his roles at Millennium, as a member of the management team and through forming the integrated Structure-Based Discovery Department.

As Director of the Millennium Structure-Based Discovery Department, Tim was responsible for global provision of protein structure and high-throughput chemical synthesis for Millennium as well as for local computational chemistry, informatics and automation capabilities. Prior to that, he was Director of Computational Chemistry at Cambridge Discovery Chemistry Ltd, and a team leader in the Computational and Structural Sciences department at SmithKline Beecham Pharmaceuticals. Tim has a PhD in Computational Chemistry and a BSc in Chemistry.
Sareum